The global vocal biomarkers market is growing at a rate of 14.5 % and is expected show a similar trend during the forecast period.
The vocal biomarkers market is chiefly driven by rise in cases of psychological, neurological and other diseases affecting speech such as depression, Attention Deficit and Disruptive Behavior Disorders, Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular Disorders, traumatic brain injury (TBI) etc. According to WHO estimates, around 350 million individuals were suffering from depression in 2016 while the Parkinson’s disease Foundation, estimated about 10 million individuals Parkinson’s patients globally in 2016. Thus growing global disease prevalence will drive vocal biomarkers market size in the coming years. Another potential area of application is the use of voice biomarkers to detect disorders in employees and soldiers. For example, the U.S. Army entered into collaboration with MIT researchers to develop voice biomarkers technology for traumatic brain injury. American Heart Association in collaboration with Beyond Verbal and Mayo Clinic has developed artificial intelligence (AI) algorithms by using machine-learning to perceive voice patterns imperceptible to human ear for initial identification of coronary heart disease.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3933
The increasing penetration of mobile technology and information technology is driving the market. The development of wearable’s coupled with the rising quality and bandwidth availability is another boon for the market for vocal biomarkers. Product development is an important strategy and the increasing collaboration between technology companies and research institutes will yield multiple benefits to both partners. For example, Sonde Health Inc., has developed a voice-based technology platform for monitoring and diagnosing diseases and conditions, has collaborated and licensed the technology from the Massachusetts Institute of Technology (MIT). Another company Beyond Verbal has developed vocal biomarket application for detecting emotions. The emotional analysis uses voice biomarkers to detect the moods such as arousal, temper etc. Beyond Verbal has also pursued the partnership strategy with Mayo Clinic, Tel Aviv University and others for the development of vocal biomarkers.
Global Vocal biomarkers Market Players:
Key players profiled in the report are Beyond Verbal, Sonde Health, Audio Profiling, IBM Corporation, Cogito Corporation and others.
Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Vocal biomarkers Market” Research Report – Forecast to 2023.
Segmentation:
The global vocal biomarkers market is segmented on the basis of type, indications and end users. Based on type the market has been segmented as frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch and others. Based on the indications, the market has been segmented as psychiatric disorders (depression, attention deficit and disruptive behavior disorders, others), neurological disorders (Parkinson’s disease (PD), Alzheimer's disease, Huntington's disease, others), respiratory disorders, cardiovascular disorders, traumatic brain injury (TBI), others) and others. Based on end users, the market has been segmented as hospitals and clinics, academic and research and others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/vocal-biomarkers-market-3933
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
Email: [email protected]
Overview:The vocal biomarker markets can achieve better growth in the coming years due to its non-invasive methods in detecting diseases.
The global market for voice biomarkers can be on a track to achieve a CAGR of 14.5% to surpass a valuation of USD 2.5 million between 2017 and 2023, which according to the Market Research Future (MRFR), is the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/3933Segments:The global report on the market for vocal biomarkers facilitates a study by providing a segmentation on the basis of indications, type, and end users.
By type, the market report has been segmented into amplitude, frequency, vocal rise or fall time, error rate, voice tremor, pitch, phonation time, and others.
By indications, the market on the vocal biomarkers can be segmented on the basis of psychiatric disorders (attention deficit & disruptive behavior disorders, depression, others), neurological disorders (Huntington's disease, Alzheimer's disease, Parkinson’s disease (PD), others), traumatic brain injury (TBI), cardiovascular disorders, respiratory disorders, and others.
Advanced research opportunities, better growth planning, hike in investment, participation from various research institutes, and others are going to lead the voice biomarker market ahead.
In South America, the growth opportunity would gain lesser acknowledgments as the backups needed to make sure of the market growth are not well-formed.
Vocal Biomarkers Market information: by type (frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch, others) by indications (psychiatric disorders (depression, Attention Deficit and Disruptive Behavior Disorders, others), neurological disorders (Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, others), Respiratory Disorders, Cardiovascular Disorders, traumatic brain injury (TBI), others), others) by end users (hospitals and clinics, academic and research, others) - Global Forecast till 2027Market HighlightsThe vocal biomarkers market is chiefly driven by rise in cases of psychological, neurological and other diseases affecting speech such as depression, Attention Deficit and Disruptive Behavior Disorders, Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular Disorders, traumatic brain injury (TBI) etc.
Thus growing global disease prevalence will drive vocal biomarkers market size in the coming years.
Another potential area of application is the use of voice biomarkers to detect disorders in employees and soldiers.
For example, the U.S. Army entered into collaboration with MIT researchers to develop voice biomarkers technology for traumatic brain injury.
American Heart Association in collaboration with Beyond Verbal and Mayo Clinic has developed artificial intelligence (AI) algorithms by using machine-learning to perceive voice patterns imperceptible to human ear for initial identification of coronary heart disease.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3933The increasing penetration of mobile technology and information technology is driving the market.
Product development is an important strategy and the increasing collaboration between technology companies and research institutes will yield multiple benefits to both partners.
